ShilpanjaliJesudason Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia

ShilpanjaliJesudason
A/Prof Shilpanjali Jesudason (MBBS PhD FRACP), is an academic nephrologist at the Royal Adelaide Hospital’s Central Northern Adelaide Renal and Transplant Service (CNARTS ) where she is Director of Dialysis, Chair of the CNARTS Clinical Research Group and Program Lead for Pregnancy and Kidney Research Australia. She is Clinical Associate Professor, University of Adelaide. From 2017- 2020 she was the National Clinical Director of Kidney Health Australia, the peak body for patients with kidney disease.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/fc7d0e421f50da47222cb8619ce0703d.jpg
First Name
Shilpanjali
Last Name
Jesudason
Institution
Country.
Australia

Friday, February 7, 2025

Time Session
9:45 a.m.
11:15 a.m.
VinayRathore Chair vinayrathoredm@aiimsraipur.edu.inIndia
  • Outcomes From the ISN Haemolytic Uraemic Syndromes Forum: A Comprehensive Review
    DavidKavanagh Speaker National Renal Complement Therapeutics Centre United Kingdom
  • Differential Diagnosis and Treatment of TMAs in Pregnancy
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Antiphospholipid Syndrome in Pregnancy
  • aHUS in Paediatric Populations
    Alison Lap-Tak Ma Speaker Hong Kong, China
  • Q&A
Parijat Hall 201
11:45 a.m.
12:45 p.m.
  • Mathematical Modelling of Diseases, Focus on Kidney Disease. Stewart Cameron Lecture
    AnitaLayton Speaker University of Waterloo
  • Q and A
  • Acceptance Speech: Roscoe Robinson Award
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
Auditorium Brahmkamal Hall
2:15 p.m.
3:45 p.m.
Prof (Dr ) SanjeevGulati Chair sgulati2002@gmail.comIndia
  • Sustainable Community Approaches to Early CKD Detection
    RonaldGansevoort Speaker Dept. Nephrology, University Medical Center Groningen
  • Kidney Disease Treatment Gaps Worldwide - Where Are the Solutions?
    AdeeraLevin Speaker Canada
  • The Promise of Emerging Therapies in Reducing the Global Kidney Disease Burden
    DavidWheeler Speaker University College LondonUnited Kingdom
  • Co-opting Patients as Partners in Kidney Care: How Do We Do It?
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Co-opting Patients as Partners in Kidney Care: How Do We Do It?
    ShyamsundarMuthuramalingam Speaker Central Adelaide Local Health Network Australia
  • Q&A
Kesar Hall 202

Thursday, February 6, 2025

Time Session
1 p.m.
2:30 p.m.
MichelleHladunewich Chair Canada
ShilpanjaliJesudason Chair Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Welcome and Background on Obstetric Nephrology Evolution
    MichelleHladunewich Speaker Canada
  • Overview of the TT Program and Toolkit Launch
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Trainer Perspective
    GhadaAnkawi Speaker King Abdulaziz University Saudi Arabia
  • Trainer Perspective
    DIVYABAJPAI Speaker India
  • Panel Discussion, Questions and Group Discussion
Mogra Hall A 404
2:45 p.m.
4:05 p.m.
MegJardine Chair NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
ShilpanjaliJesudason Chair Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Using Registry Data in Trials: Lessons on Patient Reported Outcomes from SWIFT in Australia
    RachaelMorton Speaker NHMRC Clinical Trials Centre, The University of SydneyAustralia
  • Using Registry Data in Trials: Defining Measures of Kidney Function in Observational Studies Using Routine Health Care Data
  • Using Registry Data in Trials: Lessons from Tackling AKI, H4RT, and Prepare for Kidney Care in the UK
    FergusCaskey Speaker University of Bristol, UKUnited Kingdom
  • Q and A
Kesar Hall 202